ES2B-C001-S01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ES2B-C001-S01, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer. [Phase 1]